Insmed Incorporated
Price
OptionsOpen the Sheet →FilingsNewest: 8-K, Director or officer changeOct 5 →InsidersNo open-market buys. 9 insiders sold $122.0M, 116 of 152 sales on a 10b5-1 plan.→Financing →PeersClosest companies: BBIO, PTCT, MREO→
From the filings
Figures
- Revenue
- $1.14Blast 12 months
- Net income
- −$875.3Mlast 12 months
- Operating cash flow
- −$895.7Mlast 12 months
- Cash and equivalents
- $544.8Mat the last balance sheet
- Total debt
- $543.5Mat the last balance sheet
- Shares outstanding
- 218.3M shareson issue